Biosimilar product for infliximab (Remicade.) Infliximab-DYYB is GMC's preferred agent, however, medication selection will be driven by payer, patient, and prescriber choice. This is NOT an approved automatic substitution. Infusion guidelines are the same as those for Remicade.
Biosimilar product for infliximab (Remicade.) Infliximab-DYYB is GMC's preferred agent, however, medication selection will be driven by payer, patient, and prescriber choice. This is NOT an approved automatic substitution. Infusion guidelines are the same as those for Remicade.